Move For Surgery - A Novel Preconditioning Program (MFS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03689634|
Recruitment Status : Recruiting
First Posted : September 28, 2018
Last Update Posted : February 21, 2019
|Condition or disease||Intervention/treatment||Phase|
|Lung Cancer, Nonsmall Cell||Device: Move For Surgery Preconditioning Program using a Wearable Activity Tracker (Fitbit) Intervention Group||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||186 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Care Provider, Investigator)|
|Official Title:||Move For Surgery - A Novel Preconditioning Program to Optimize Health Before Thoracic Surgery: A Randomized Controlled Trial|
|Actual Study Start Date :||October 15, 2018|
|Estimated Primary Completion Date :||October 1, 2020|
|Estimated Study Completion Date :||October 1, 2020|
|Experimental: Move For Surgery Preconditioning Program Intervention Group||
Device: Move For Surgery Preconditioning Program using a Wearable Activity Tracker (Fitbit) Intervention Group
Participants randomized to this group will be be provided with a wearable activity tracker (Fitbit) for the duration of the study and asked to reach daily step goals.
|No Intervention: Standard Preoperative Care Group|
- The primary outcome of the comparative trial will be length of stay (LOS) in hospital after surgery, which will also be used to measure speed of recovery from surgery and postoperative complications. [ Time Frame: 24 months ]LOS is a good surrogate measure for the speed of recovery from surgery (patients who recover faster leave hospital earlier) and postoperative complications (patients who do not suffer complications leave the hospital earlier).
- Secondary outcome will include differences in the 36-Item Short Form Health Survey (SF-36) scores before and after the intervention. [ Time Frame: 24 months ]The quality of life as reported by patients will be compared.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03689634
|Contact: Yogita Patel||905-522-1155 ext firstname.lastname@example.org|
|St. Joseph's Healthcare Hamilton||Recruiting|
|Hamilton, Ontario, Canada, L8N 4A6|
|Contact: Yogita Patel 905-522-1155 ext 35096 email@example.com|